Protein Sequencing Market Synopsis and Industry Overview 2019

Protein sequencing can be defined as the methods which are used to determine the amino acid sequence of peptides or proteins for analysing the sequence. It is a popular novo sequencing method which enables the researchers to obtain the information regarding protein confirmation.

Market Research Future (MRFR) proclaims that the global protein sequencing market is likely to expand at a CAGR of 3.6% during the forecast period (2018-2023). The surging focus on target-based drug development by the biotechnological companies is likely to contribute to the market growth.

Experimental methods and computational methods like Mass Spectrometry and Edman degradation are used for protein sequencing.

Avail a Free Sample https://www.marketresearchfuture.com/sample_request/6828

Market Potential and Pitfalls

The global protein sequencing market is witnessing a sturdy growth rate owing to the surging focus on target-based drug development by the pharmaceutical and biotechnological companies, advancements made in the clinical mass spectrometry and analytical techniques, and rising financial support by the private and public sector for proteomic research. For instance, the National Cancer Institute Office of Cancer Clinical Proteomics Research offers funding opportunities for proteomics research.

Recent advancements made in the analytical methods and novo peptide-sequencing methods with the application of neural networks have created new opportunities for the market to expand. For instance, technological advancements in mass spectrometer are likely to favor its growth. The surging funding on proteomics research in several developed and developing economies is likely to contribute to market growth.

Global Protein Sequencing Market: Segmental Analysis

The global protein sequencing market has been segmented on the basis of technology, products and services, and application.

By mode of products and services, the global protein sequencing market has been segmented into instruments, reagent and consumables, protein sequencing services, and analysis products/software. Among these, the reagents and consumables segment command for the largest share owing to the ongoing advancements in protein sequencing technologies coupled with the surging number of sequencing procedures.

By mode of technology, the global protein sequencing market has been segmented into Edman degradation and mass spectrometry.

By mode of application, the global protein sequencing market has been segmented into genetic engineering, biotherapeutics, and others. Among these, the biotherapeutics segment is likely to expand at the fastest rate in the coming years. The growth can be ascribed to the benefits of protein sequencing-based approaches for drug development processes, surging demand for targeted drug therapy, advancing technology that offer accurate protein sequencing with the help of mass spectrometry, and growing antibiotic resistance of microbes.

By mode of end-users, the global protein sequencing market has been segmented into academic institutes and research centers, pharmaceutical and biotechnology companies, and others.

Access Detailed Report Page Along with List of Figures and List of Tables on https://www.marketresearchfuture.com/reports/protein-sequencing-market-6828

Competitive Dashboard

The prominent players operating in the global protein sequencing market comprises

Charles River Laboratories

Bioinformatics Solutions

Proteome Factory

Agilent Technologies Inc.

Selvita

Rapid Novor Inc.

Shimadzu Corporation

SGS

Waters Corporation

and Thermo Fisher Scientific Inc.

Regional Insights

Geographically, the protein sequencing market spans across regions namely, America, Asia Pacific, Europe, and the Middle East & Africa.

Considering the global scenario, the American region is considered to dominate the global market due to the surging application of protein sequencing in proteomic research, high availability of research funding, and the development of protein sequencing in this region.

The European region is estimated to occupy the second spot in the global market. The growth has been ascribed to the increased availability of funding along with infrastructure for research and rising proteomics research. For instance, a leading proteomics company in Switzerland, Biognosys, raised funds for making proteomics a broader segment in life science research in July 2017.

The Asia Pacific region is likely to expand at the fastest growth rate due to the increased funding for the healthcare sector, rising number of pharmaceutical companies, and growing expenditure on R&D activities in this region.

Ask for an Exclusive Discount on https://www.marketresearchfuture.com/check-discount/6828

Industry Updates

In 2019: Natera, a globally acknowledged genetic testing and diagnostics company and one of the leaders in cell-free DNA testing has transformed how the patients and doctors manage genetic disease and planned to commercialize a research-use-only service for exome sequencing of circulating tumor DNA by using plasma samples from patients suffering from cancer.

About Market Research Future: Our team have supreme objective to provide the optimum quality market research and intelligence services to our clients. market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact:

Market Research Future

+1 646 845 9312

Email: sales@marketresearchfuture.com